DR. SAMUEL E. GANDY, M.D.
Neurology in New York, NY

License number
New York MD418573
Category
Neurology
Type
Neurology
Address
Address
5 St # 1139 FLOOR 7TH, New York, NY 10029
Phone
(212) 241-7076
(212) 860-4952 (Fax)

Personal information

See more information about SAMUEL E. GANDY at radaris.com
Name
Address
Phone
Samuel Gandy, age 46
18733 Ilion Ave, Saint Albans, NY 11412
Samuel T Gandy
13712 130Th Ave, Jamaica, NY 11436
(718) 529-7669
Samuel T Gandy, age 46
16325 130Th Ave, Jamaica, NY 11434
Samuel E Gandy, age 99
525 89Th St, New York, NY 10128
Samuel E Gandy, age 99
67 Mills Cross Rd, Staatsburg, NY 12580
(845) 889-4621

Professional information

Samuel E Gandy Photo 1

Dr. Samuel E Gandy, New York NY - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Neurology)
Address:
Mount Sinai Medical Ctr Neurlgy
1 Gustave L Levy Pl SUITE 1494, New York 10029
(212) 241-7076 (Phone)
Mount Sinai Hospital Neurology
5 E 98Th St SUITE 7, New York 10029
(212) 241-7076 (Phone)
Certifications:
Neurology, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Medical University of South Carolina
Graduated: 1982
Cornell Med Ctr/Ny Hosp
Columbia U/Presbyterian Med Ctr


Samuel Evans Gandy Photo 2

Samuel Evans Gandy, New York NY

Specialties:
Neurology
Work:
Samuel Kenan
5 E 98Th St, New York, NY 10029
Education:
Medical University of South Carolina (1982)


Samuel Gandy Photo 3

Professor At Mount Sinai School Of Medicine

Location:
Greater New York City Area
Industry:
Research


Samuel E. Gandy Photo 4

Samuel E. Gandy, Nyc NY

Specialties:
Neurologist
Address:
5 East 98Th Street, 7Th Floor, Nyc, NY 10029
Education:
Medical School - MD, Medical University of South Carolina
New York Hospital Cornell University Med Ctr (Residency - Neurology)
Columbia University College of Physicians & Surgeons (Internship - Internal Medicine)
Languages:
English
Awards and Publications:
Gandy S, DeKosky ST. Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. Annual review of medicine 2013; 64., Sproul AA, Jacob S, Pre D, Kim SH, Nestor MW, Navarro-Sobrino M, Santa-Maria I, Zimmer M, Aubry S, Steele JW, Kahler DJ, Dranovsky A, Arancio O, Crary JF, Gandy S, Noggle SA. Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors. PloS one 2014; 9(1)., Kim SH, Fraser PE, Westaway D, St George-Hyslop PH, Ehrlich ME, Gandy S. Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals. The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 Mar; 30(11)., Gandy S, Haroutunian V, DeKosky ST, Sano M, Schadt EE. CR1 and the . Biological psychiatry 2013 Mar; 73(5)., Steele JW, Ju S, Lachenmayer ML, Liken J, Stock A, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, Wang R, Ringe D, Protter AA, Martins RN, Ehrlich ME, Yue Z, Petsko GA, Gandy S. Latrepirdine stimulates autophagy and reduces accumulation of a-synuclein in cells and in mouse brain. Molecular psychiatry 2013 Aug; 18(8)., Lane RF, Steele JW, Cai D, Ehrlich ME, Attie AD, Gandy S. Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-ß peptide. The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 Apr; 33(16)., Seeger M, Nordstedt C, Petanceska S, Kovacs DM, Gouras GK, Hahne S, Fraser P, Levesque L, Czernik AJ, George-Hyslop PS, Sisodia SS, Thinakaran G, Tanzi RE, Greengard P, Gandy S. Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proceedings of the National Academy of Sciences of the United States of America 1997 May; 94(10)., Steele JW, Lachenmayer ML, Ju S, Stock A, Liken J, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, Wang R, Ringe D, Fraser P, Westaway D, St George-Hyslop PH, Szabo P, Relkin NR, Buxbaum JD, Glabe CG, Protter AA, Martins RN, Ehrlich ME, Petsko GA, Yue Z, Gandy S. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Molecular psychiatry 2013 Aug; 18(8)., De Gasperi R, Gama Sosa MA, Kim SH, Steele JW, Shaughness MC, Maudlin-Jeronimo E, Hall AA, Dekosky ST, McCarron RM, Nambiar MP, Gandy S, Ahlers ST, Elder GA. Acute blast injury reduces brain abeta in two rodent species. Frontiers in neurology 2012; 3., Mitsis EM, Bender HA, Kostakoglu L, Machac J, Martin J, Woehr JL, Sewell MC, Aloysi A, Goldstein MA, Li C, Sano M, Gandy S. A consecutive case series experience with [18?F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition. Molecular neurodegeneration 2014; 9., Gandy S, Haroutunian V, DeKosky ST, Sano M, Schadt EE. CR1 and the . Biological psychiatry 2013 Mar; 73(5)., Lane RF, St George-Hyslop P, Hempstead BL, Small SA, Strittmatter SM, Gandy S. Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 Oct; 32(41)., Gandy S, Simon AJ, Steele JW, Lublin AL, Lah JJ, Walker LC, Levey AI, Krafft GA, Levy E, Checler F, Glabe C, Bilker WB, Abel T, Schmeidler J, Ehrlich ME. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Annals of neurology 2010 Aug; 68(2)., Hata S, Gandy S, Suzuki T, E. Alcadein cleavages by amyloid-beta precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating gamma-secretase dysfunction.. The Journal of Biological Chemistry 2009; 284: 36024-36033., Lane RF, Raines SM, Steele JW, Ehrlich ME, Lah JA, Small SA, Tanzi RE, Attie AD, Gandy S. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 Sep; 30(39)., Arthur Cherkin Memorial Award in Geriatric Medicine, Xu H, Sweeney D, Greengard P, Gandy S. Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system. Proceedings of the National Academy of Sciences of the United States of America 1996 Apr; 93(9)., Xu H, Sweeney D, Wang R, Thinakaran G, Lo AC, Sisodia SS, Greengard P, Gandy S. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proceedings of the National Academy of Sciences of the United States of America 1997 Apr; 94(8)., Zhu L, Su M, Lucast L, Liu L, Netzer WJ, Gandy SE, Cai D. Dynamin 1 regulates amyloid generation through modulation of BACE-1. PloS one 2012; 7(9)., Zhu L, Zhong M, Zhao J, Rhee H, Caesar I, Knight EM, Volpicelli-Daley L, Bustos V, Netzer W, Liu L, Lucast L, Ehrlich ME, Robakis NK, Gandy SE, Cai D. Reduction of synaptojanin 1 accelerates Aß clearance and attenuates cognitive deterioration in an Alzheimer mouse model. The Journal of biological chemistry 2013 Nov; 288(44).
About:
Sam Gandy, MD, PhD, is Mount Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, Associate Director of the Mount Sinai Alzheimer's Disease Rese...


Samuel Gandy Photo 5

Treatment Of Amyloidosis Associated With Alzheimer Disease

US Patent:
5242932, Sep 7, 1993
Filed:
Dec 17, 1991
Appl. No.:
7/809174
Inventors:
Samuel E. Gandy - New York NY
Gregg L. Caporaso - New York NY
Paul Greengard - New York NY
Assignee:
The Rockefeller University - New York NY
International Classification:
A01N 4316, A01N 4342, A61K 3147
US Classification:
514313
Abstract:
Agents which modulate or affect the intracellular trafficking and processing of proteins in the mammalian cell can be utilized to affect the trafficking and processing of APP, thereby inhibiting production of Alzheimer type amyloidosis. Particularly useful agents are chloroquine and its related derivatives such as primaquine.


Samuel Gandy Photo 6

Treatment Of Amyloidosis Associated With Alzheimer Disease Using Modulators Of Protein Phosphorylation

US Patent:
5385915, Jan 31, 1995
Filed:
Jun 7, 1993
Appl. No.:
8/073112
Inventors:
Joseph D. Buxbaum - Flushing NY
Samuel E. Gandy - New York NY
Paul Greengard - New York NY
Assignee:
The Rockefeller University - New York NY
International Classification:
A01N 4316, A01N 4342, A61K 3147
US Classification:
514313
Abstract:
A method of regulating phosphorylation of proteins involved in controlling processing or function of key proteins found in intracellular neurofibrillary tangles and extracellular amyloid plaques associated with Alzheimer disease comprising introducing an effective amount of a kinase modulator or phosphatase modulator, the modulator capable of increasing or decreasing the rate of proteolytic processing, or modulating the function, of said key proteins.


Samuel Gandy Photo 7

Method Of Screening For Modulators Of Amyloid Formation

US Patent:
5348963, Sep 20, 1994
Filed:
May 26, 1993
Appl. No.:
8/053415
Inventors:
Samuel E. Gandy - New York NY
Gregg L. Caporaso - New York NY
Paul Greengard - New York NY
Assignee:
The Rockefeller University - New York NY
International Classification:
A01N 4316, A01N 4342, A61K 3147
US Classification:
514313
Abstract:
Agents which modulate or affect the intracellular trafficking and processing of proteins in the mammalian cell can be utilized to affect the trafficking and processing of APP, thereby inhibiting production of Alzheimer type amyloidosis. Particularly useful agents are chloroquine and its related derivatives such as primaquine.


Samuel Gandy Photo 8

Use Of Phosphoprotein Patterns For Diagnosis Of Neurological And Psychiatric Disorders

US Patent:
4874694, Oct 17, 1989
Filed:
Apr 7, 1987
Appl. No.:
7/035347
Inventors:
Samuel E. Gandy - New York NY
Paul Greengard - New York NY
Assignee:
The Rockefeller University - New York NY
International Classification:
C12Q 148, C07G 1700, C07G 1500, C07K 312
US Classification:
435 15
Abstract:
A diagnostic method for neurological and psychiatric disorders utilizes the cerebrospinal fluid incubated in the presence of 32-P labelled ATP and an appropriate protein kinase. After termination of the reaction, a sample is applied to gels for electrophoresis. Subsequent autoradiography results in a disease-specific protein pattern that can be used for diagnosis of disorders such as Alzheimer disease, Huntington disease, Parkinson disease, dystonia ataxia, schizophrenia, epilepsy brain tumors, brain irradiation, head trauma, and acute and chronic encephalitic and vascular disease.